BiotechTube
Home/Pipeline/Pancreatic Cancer Antigen Discovery

Pancreatic Cancer Antigen Discovery

Pancreatic Cancer

ResearchActive

Key Facts

Indication
Pancreatic Cancer
Phase
Research
Status
Active
Company
CogNano

About CogNano

CogNano uses alpaca-derived VHH antibodies and AI to discover novel biomarkers and drug targets for unmet medical needs in oncology.

View full company profile

Therapeutic Areas

OncologyInfectious Diseases

Other Pancreatic Cancer Drugs

DrugCompanyPhase
Ampligen® (rintatolimod)AIM ImmunoTechEarly Access Program
HBM9027Harbour BioMedPhase 1
Small-Molecule TherapeuticAIkido LabsPre-clinical
AHPBA IRE RegistryAngioDynamicsPost-Market Registry
SIMBs + ImmunotherapyAdvanced MicrobubblesPre-clinical
CLS-014CLS TherapeuticsPre-clinical
SOMA PlatformCoherence NeuroPre-clinical
NP-G2-044Novita PharmaceuticalsPhase 2a
Pritumumab (PTB)Nascent BiotechPhase II (Planned)
Pancreatic Cancer TestMosaique DiagnosticDevelopment
Iontophoretic SystemContinuity BiosciencesPre-clinical
Lixumistat (IM156)ImmunoMet TherapeuticsPhase 1b